Onivyde: Changing The Treatment Game For Metastatic Pancreatic Cancer With Rinotecan Liposome
商品資訊
定價
：NT$ 520 元無庫存，下單後進貨(到貨天數約30-45天)
可得紅利積點：15 點
相關商品
商品簡介
商品簡介
In a groundbreaking development, a beacon of hope emerges for those battling pancreatic cancer. Following a decade-long hiatus, the FDA has granted approval to a revolutionary drug regimen, heralding a new dawn in the fight against metastatic pancreatic adenocarcinoma (mPDAC). Onivyde, an injectable medication crafted by Ipsen, takes center stage, offering a lifeline alongside oxaliplatin, fluorouracil, and leucovorin. As patients grapple with an aggressive adversary boasting a mere eight to eleven-month life expectancy, this milestone stands as a testament to resilience and progress. Backed by a rigorous trial encompassing 770 chemotherapy-na鴳e individuals, the regimen showcased unprecedented efficacy, elevating survival rates and response rates to unprecedented heights. Amidst the backdrop of adversity, this approval not only marks a triumph over disease but also signifies a beacon of hope for countless individuals embarking on the arduous journey towards healing.
您曾經瀏覽過的商品
購物須知
外文書商品之書封，為出版社提供之樣本。實際出貨商品，以出版社所提供之現有版本為主。部份書籍，因出版社供應狀況特殊，匯率將依實際狀況做調整。
無庫存之商品，在您完成訂單程序之後，將以空運的方式為你下單調貨。為了縮短等待的時間，建議您將外文書與其他商品分開下單，以獲得最快的取貨速度，平均調貨時間為1~2個月。
為了保護您的權益，「三民網路書店」提供會員七日商品鑑賞期(收到商品為起始日)。
若要辦理退貨，請在商品鑑賞期內寄回，且商品必須是全新狀態與完整包裝(商品、附件、發票、隨貨贈品等)否則恕不接受退貨。